Hepatic IRF8 Expression Suppresses Hepatocellular Carcinoma Progression and Enhances the Response to Anti-PD-1 Therapy

By
Justin.choi
-
0
223
Scientists identified interferon regulatory factor (IRF8) as an important prognostic biomarker in hepatocellular carcinoma patients which predicted the response and sensitivity to anti-PD-1 therapy.
[Hepatology]
7992332 {7992332:EEEEEEEE} 1 apa 50 default 1 170437 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Abstract